gnudi
Selected indexed studies
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. (N Engl J Med, 2019) [PMID:30990260]
- Diabetic Nephropathy: An Overview. (Methods Mol Biol, 2020) [PMID:31701441]
- Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies. (Metabolism, 2021) [PMID:34560098]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. (2019) pubmed
- Diabetic Nephropathy: An Overview. (2020) pubmed
- Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies. (2021) pubmed
- Nodular fat necrosis in the feline and canine abdomen. (2000) pubmed
- Carcinogenic effects of long-term exposure from prenatal life to glyphosate and glyphosate-based herbicides in Sprague-Dawley rats. (2025) pubmed
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. (2019) pubmed
- Martha Teach Gnudi, 1908-1976. (1976) pubmed
- Martha Teach Gnudi, 1908-1976. (1976) pubmed
- Angiopoietins and diabetic nephropathy. (2016) pubmed
- Neurite outgrowth inhibitor-B in physiology and disease. (2026) pubmed